Concepedia

Publication | Open Access

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

DOIFull Paper Access

152

Citations

14

References

2021

Year

Binghe Xu, Qingyuan Zhang, Pin Zhang, Xichun Hu, Wěi Li, Zhongsheng Tong, Tao Sun, Yuee Teng, Xinhong Wu, Quchang Ouyang,
Nature Medicine

References

YearCitations

Page 1